These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 19219089)

  • 21. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution.
    Saha SK; Naheed A; El Arifeen S; Islam M; Al-Emran H; Amin R; Fatima K; Brooks WA; Breiman RF; Sack DA; Luby SP;
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S75-81. PubMed ID: 19191622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine.
    Long SS
    Clin Infect Dis; 2005 Jul; 41(1):30-4. PubMed ID: 15937759
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibiotic resistance in Latin America: a cause for alarm.
    Valenzuela MT; de Quadros C
    Vaccine; 2009 Aug; 27 Suppl 3():C25-8. PubMed ID: 19540634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
    Rodgers GL; Arguedas A; Cohen R; Dagan R
    Vaccine; 2009 Jun; 27(29):3802-10. PubMed ID: 19446378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promises and challenges of pneumococcal conjugate vaccines for the developing world.
    Grijalva CG; Edwards KM
    Clin Infect Dis; 2006 Sep; 43(6):680-2. PubMed ID: 16912938
    [No Abstract]   [Full Text] [Related]  

  • 26. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany.
    Rückinger S; van der Linden M; Reinert RR; von Kries R; Burckhardt F; Siedler A
    Vaccine; 2009 Jun; 27(31):4136-41. PubMed ID: 19406190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006.
    Steenhoff AP; Wood SM; Rutstein RM; Wahl A; McGowan KL; Shah SS
    Pediatr Infect Dis J; 2008 Oct; 27(10):886-91. PubMed ID: 18776825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The coming of age of niche vaccines? Effect of vaccines on resistance profiles in Streptococcus pneumoniae.
    McGee L
    Curr Opin Microbiol; 2007 Oct; 10(5):473-8. PubMed ID: 17936680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine.
    Aguiar SI; Serrano I; Pinto FR; Melo-Cristino J; Ramirez M;
    Clin Microbiol Infect; 2008 Sep; 14(9):835-43. PubMed ID: 18844684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The shifting dynamics of pneumococcal invasive disease after the introduction of the pneumococcal 7-valent conjugated vaccine: toward the new pneumococcal conjugated vaccines.
    Greenberg D
    Clin Infect Dis; 2009 Jul; 49(2):213-5. PubMed ID: 19508164
    [No Abstract]   [Full Text] [Related]  

  • 31. Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era.
    Pichichero ME; Casey JR
    Pediatr Infect Dis J; 2007 Oct; 26(10 Suppl):S12-6. PubMed ID: 18049375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of capsular switch on invasive pneumococcal disease incidence in a vaccinated population.
    Temime L; Boelle PY; Opatowski L; Guillemot D
    PLoS One; 2008 Sep; 3(9):e3244. PubMed ID: 18802466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heptavalent Pneumococcal Conjugate Vaccine: growing knowledge and its implications for Italy.
    Durando P; Sticchi C; Compagnino F; Ansaldi F; Sticchi L; Gasparini R; Castiglia P; Lugarini J; Alberti M; Icardi G
    J Prev Med Hyg; 2008 Mar; 49(1):34-46. PubMed ID: 18792532
    [No Abstract]   [Full Text] [Related]  

  • 34. The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease.
    Hausdorff WP
    Vaccine; 2007 Mar; 25(13):2406-12. PubMed ID: 17055620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. National paediatric immunization program of high risk groups: no effect on the incidence of invasive pneumococcal diseases.
    Rendi-Wagner P; Paulke-Korinek M; Kundi M; Burgmann H; Georgopoulos A; Vécsei A; Kollaritsch H
    Vaccine; 2009 Jun; 27(30):3963-8. PubMed ID: 19393711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pneumococcal disease in a paediatric population in a hospital of central Italy: a clinical and microbiological case series from 1992 to 2006.
    Montagnani F; Fanetti A; Stolzuoli L; Croci L; Arena F; Zanchi A; Cellesi C
    J Infect; 2008 Mar; 56(3):179-84. PubMed ID: 18222005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona.
    Muñoz-Almagro C; Esteva C; de Sevilla MF; Selva L; Gene A; Pallares R
    J Infect; 2009 Aug; 59(2):75-82. PubMed ID: 19576637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh.
    Brooks WA; Breiman RF; Goswami D; Hossain A; Alam K; Saha SK; Nahar K; Nasrin D; Ahmed N; El Arifeen S; Naheed A; Sack DA; Luby S
    Am J Trop Med Hyg; 2007 Nov; 77(5):795-801. PubMed ID: 17984328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
    Dagan R
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
    Jacobs MR
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):619-35. PubMed ID: 18847402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.